Serina Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-7.9M | $-7.9M | — | $999.0K |
| FY2022 | $-5.9M | $-5.9M | — | $760.0K |
| FY2023 | $-2.5M | $-3.0M | $504.0K | $25.0K |
| FY2024 | $-17.1M | $-17.2M | $22.0K | $2.6M |
| FY2025 | $-18.0M | $-18.0M | $59.0K | — |